Literature DB >> 12791867

Identification by subtractive hybridization of a novel insertion element specific for two widespread Burkholderia cepacia genomovar III strains.

Lixia Liu1, Theodore Spilker, Tom Coenye, John J LiPuma.   

Abstract

Species of the Burkholderia cepacia complex cause chronic and life-threatening infections in persons with cystic fibrosis. Epidemic strains infect multiple patients, reside primarily in genomovar III, and have an apparent enhanced capacity for human infection and/or interpatient transmission. By using subtractive hybridization, a novel insertion element, designated IS1363, was identified in epidemic strain PHDC, known to infect many cystic fibrosis patients in the mid-Atlantic region of the United States. IS1363 was also found in most isolates of the ET12 lineage, responsible for infecting large numbers of patients in Ontario, Canada, and the United Kingdom. Southern blot analysis demonstrated that whereas multiple copies of IS1363 were present in strain PHDC, only one copy was present in ET12 isolates. IS1363 was used to probe a collection of 943 B. cepacia complex isolates, representing all nine genomovars, recovered from 761 cystic fibrosis patients or the natural environment. IS1363 was not found in other genomovar III strains and, with the exception of B. ambifaria, was absent from other B. cepacia complex species. Genotyping analyses of all IS1363-positive isolates demonstrated that strain PHDC was more widely distributed in the United States than previously appreciated; 212 cystic fibrosis patients in 24 states were identified as being infected with PHDC.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12791867      PMCID: PMC156561          DOI: 10.1128/JCM.41.6.2471-2476.2003

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  37 in total

Review 1.  Taxonomy and identification of the Burkholderia cepacia complex.

Authors:  T Coenye; P Vandamme; J R Govan; J J LiPuma
Journal:  J Clin Microbiol       Date:  2001-10       Impact factor: 5.948

2.  Identification of new transposable genetic elements in Burkholderia pseudomallei using subtractive hybridisation.

Authors:  N F Brown; A E Lew; I R Beacham
Journal:  FEMS Microbiol Lett       Date:  2000-02-01       Impact factor: 2.742

3.  Disproportionate distribution of Burkholderia cepacia complex species and transmissibility markers in cystic fibrosis.

Authors:  J J LiPuma; T Spilker; L H Gill; P W Campbell; L Liu; E Mahenthiralingam
Journal:  Am J Respir Crit Care Med       Date:  2001-07-01       Impact factor: 21.405

4.  Burkholderia cepacia complex infection in Italian patients with cystic fibrosis: prevalence, epidemiology, and genomovar status.

Authors:  A Agodi; E Mahenthiralingam; M Barchitta; V Gianninò; A Sciacca; S Stefani
Journal:  J Clin Microbiol       Date:  2001-08       Impact factor: 5.948

5.  Identification by subtractive hybridization of a novel insertion sequence specific for virulent strains of Porphyromonas gingivalis.

Authors:  K Sawada; S Kokeguchi; H Hongyo; S Sawada; M Miyamoto; H Maeda; F Nishimura; S Takashiba; Y Murayama
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

6.  Identification of a Burkholderia mallei polysaccharide gene cluster by subtractive hybridization and demonstration that the encoded capsule is an essential virulence determinant.

Authors:  D DeShazer; D M Waag; D L Fritz; D E Woods
Journal:  Microb Pathog       Date:  2001-05       Impact factor: 3.738

7.  DNA-Based diagnostic approaches for identification of Burkholderia cepacia complex, Burkholderia vietnamiensis, Burkholderia multivorans, Burkholderia stabilis, and Burkholderia cepacia genomovars I and III.

Authors:  E Mahenthiralingam; J Bischof; S K Byrne; C Radomski; J E Davies; Y Av-Gay; P Vandamme
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

8.  Detection of bacterial virulence genes by subtractive hybridization: identification of capsular polysaccharide of Burkholderia pseudomallei as a major virulence determinant.

Authors:  S L Reckseidler; D DeShazer; P A Sokol; D E Woods
Journal:  Infect Immun       Date:  2001-01       Impact factor: 3.441

9.  Identification by subtractive hybridization of sequences specific for Salmonella enterica serovar enteritidis.

Authors:  P G Agron; R L Walker; H Kinde; S J Sawyer; D C Hayes; J Wollard; G L Andersen
Journal:  Appl Environ Microbiol       Date:  2001-11       Impact factor: 4.792

10.  Identification of genes present specifically in a virulent strain of Klebsiella pneumoniae.

Authors:  Y C Lai; S L Yang; H L Peng; H Y Chang
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

View more
  10 in total

1.  Development of goose- and duck-specific DNA markers to determine sources of Escherichia coli in waterways.

Authors:  Matthew J Hamilton; Tao Yan; Michael J Sadowsky
Journal:  Appl Environ Microbiol       Date:  2006-06       Impact factor: 4.792

2.  Transmission of Burkholderia cepacia complex: evidence for new epidemic clones infecting cystic fibrosis patients in Italy.

Authors:  S Campana; G Taccetti; N Ravenni; F Favari; L Cariani; A Sciacca; D Savoia; A Collura; E Fiscarelli; G De Intinis; M Busetti; A Cipolloni; A d'Aprile; E Provenzano; I Collebrusco; P Frontini; G Stassi; M Trancassini; D Tovagliari; A Lavitola; C J Doherty; T Coenye; J R W Govan; P Vandamme
Journal:  J Clin Microbiol       Date:  2005-10       Impact factor: 5.948

3.  Development of a multiple-locus variable-number tandem-repeat typing scheme for genetic fingerprinting of Burkholderia cenocepacia and application to nationwide epidemiological analysis.

Authors:  Christine Segonds; Michelle Thouverez; Antoine Barthe; Nadège Bossuet-Greif; Lenka Tisseyre; Patrick Plésiat; Gilles Vergnaud; Gérard Chabanon; Christine Pourcel
Journal:  J Clin Microbiol       Date:  2014-11-19       Impact factor: 5.948

4.  Recovery of Burkholderia cenocepacia strain PHDC from cystic fibrosis patients in Europe.

Authors:  T Coenye; T Spilker; A Van Schoor; J J LiPuma; P Vandamme
Journal:  Thorax       Date:  2004-11       Impact factor: 9.139

5.  Use of suppression-subtractive hybridization to identify genes in the Burkholderia cepacia complex that are unique to Burkholderia cenocepacia.

Authors:  Steve P Bernier; Pamela A Sokol
Journal:  J Bacteriol       Date:  2005-08       Impact factor: 3.490

6.  Precise measurement of the fitness effects of spontaneous mutations by droplet digital PCR in Burkholderia cenocepacia.

Authors:  Anita Rana; David Patton; Nathan T Turner; Marcus M Dillon; Vaughn S Cooper; Way Sung
Journal:  Genetics       Date:  2021-10-02       Impact factor: 4.402

7.  Identification of a genetic marker of Helicobacter pylori strains involved in gastric extranodal marginal zone B cell lymphoma of the MALT-type.

Authors:  P Lehours; S Dupouy; B Bergey; A Ruskoné-Foumestraux; J C Delchier; R Rad; F Richy; J Tankovic; F Zerbib; F Mégraud; A Ménard
Journal:  Gut       Date:  2004-07       Impact factor: 23.059

8.  The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients.

Authors:  Matthew T G Holden; Helena M B Seth-Smith; Lisa C Crossman; Mohammed Sebaihia; Stephen D Bentley; Ana M Cerdeño-Tárraga; Nicholas R Thomson; Nathalie Bason; Michael A Quail; Sarah Sharp; Inna Cherevach; Carol Churcher; Ian Goodhead; Heidi Hauser; Nancy Holroyd; Karen Mungall; Paul Scott; Danielle Walker; Brian White; Helen Rose; Pernille Iversen; Dalila Mil-Homens; Eduardo P C Rocha; Arsenio M Fialho; Adam Baldwin; Christopher Dowson; Bart G Barrell; John R Govan; Peter Vandamme; C Anthony Hart; Eshwar Mahenthiralingam; Julian Parkhill
Journal:  J Bacteriol       Date:  2008-10-17       Impact factor: 3.490

9.  Comparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia mallei.

Authors:  Mark A Schell; Lyla Lipscomb; David DeShazer
Journal:  J Bacteriol       Date:  2008-01-25       Impact factor: 3.490

Review 10.  Burkholderia cenocepacia Infections in Cystic Fibrosis Patients: Drug Resistance and Therapeutic Approaches.

Authors:  Viola C Scoffone; Laurent R Chiarelli; Gabriele Trespidi; Massimo Mentasti; Giovanna Riccardi; Silvia Buroni
Journal:  Front Microbiol       Date:  2017-08-22       Impact factor: 5.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.